BRIDGEBIO PHARMA INC's ticker is and the CUSIP is 10806XAD4. A total of 45 filers reported holding BRIDGEBIO PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PALISADE CAPITAL MANAGEMENT, LP | 1,500,000 | $1,138,650 | 0.03% |
| SG Americas Securities, LLC | 22,000 | $1,684 | 0.02% |
| UBS ASSET MANAGEMENT AMERICAS INC | 53,388,000 | $40,339,119 | 0.02% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 2,000,000 | $1,500,000 | 0.01% |
| AMERIPRISE FINANCIAL INC | 29,000,000 | $21,605,000 | 0.01% |
| BNP Paribas Asset Management Holding S.A. | 2,500,000 | $1,889 | 0.01% |
| NEW YORK STATE COMMON RETIREMENT FUND | 4,336,000 | $3,230 | 0.01% |
| DEUTSCHE BANK AG\ | 8,046,000 | $5,994,270 | 0.00% |
| WELLS FARGO & COMPANY/MN | 16,561,000 | $12,567,480 | 0.00% |
| FIRST HAWAIIAN BANK | 126,000 | $93,870 | 0.00% |
| CITIGROUP INC | 4,240,000 | $3,158,800 | 0.00% |
| Russell Investments Group, Ltd. | 1,515,000 | $1,157,847 | 0.00% |
| FMR LLC | 26,520,000 | $19,757,400 | 0.00% |
| AQR Arbitrage LLC | 60,000 | $45,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 10,597,000 | $7,894,765 | 0.00% |
| Marcum Wealth, LLC | 10,000 | $7,450 | 0.00% |
| GOLDMAN SACHS GROUP INC | 5,000,000 | $3,725,000 | 0.00% |
| Leucadia National | 135,000 | $100,988 | 0.00% |
| STATE STREET CORP | 19,100,000 | $14,534,127 | 0.00% |
| MORGAN STANLEY | 3,900,000 | $2,905,500 | 0.00% |
This page lists BRIDGEBIO PHARMA INC's shareholders in Q3 2023. To view BRIDGEBIO PHARMA INC's shareholder history, click here.